The signal depends on the interaction between luciferase and its luciferin substrate. In one configuration, luciferase activity is paired with administered luciferin; in another, organisms express bioluminescent reporter genes that support light production. These alternatives let investigators associate detected emission with biological activity or with the presence and behavior of a labeled biological system in a living subject.
Light produced within the subject must pass through tissue before a sensitive camera captures it. This connects biological activity with an observable optical signal without requiring tissue removal at each observation. Because the camera records emitted photons from the living subject, investigators can follow changes over time and compare patterns during disease progression or treatment response.
Administered luciferin provides the light-producing input for a luciferase system at the time of observation. Reporter-gene strategies instead rely on organisms that express a bioluminescent reporter, linking the signal to the presence or activity of that biological system. The choice therefore affects how researchers associate captured light with the process under study.
Researchers first use a luciferase and luciferin arrangement or a bioluminescent reporter-gene model. For luciferase systems requiring an external substrate, luciferin is administered before observation. A sensitive camera then captures photons passing through tissue, allowing the biological signal to be monitored at successive observations. This sequence supports noninvasive follow-up in living animal models.
The approach can address several medical-model questions without relying on repeated invasive sampling. Investigators can monitor tumor growth, follow infection, examine cell migration, and track gene expression in living animal models. The same approach can also be used during treatment studies, where serial observations reveal whether disease-related activity changes over time and support assessment of treatment response.
Serial observations can show whether the optical signal changes as disease progresses or as treatment is applied. Because the same subject can be followed repeatedly, investigators can compare observations across time rather than depending only on separate endpoint assessments. This supports evaluation of treatment response while reducing invasive sampling and improving the efficiency of animal-model experiments.